Sylvie Bretin

438 total citations
17 papers, 356 citations indexed

About

Sylvie Bretin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Sylvie Bretin has authored 17 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Sylvie Bretin's work include Neuroscience and Neuropharmacology Research (13 papers), Tryptophan and brain disorders (3 papers) and Stress Responses and Cortisol (2 papers). Sylvie Bretin is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Tryptophan and brain disorders (3 papers) and Stress Responses and Cortisol (2 papers). Sylvie Bretin collaborates with scholars based in France, United States and Greece. Sylvie Bretin's co-authors include Joël Prémont, C. Gauchy, Véronique Rogemond, Jacques Glowinski, Jérôme Honnorat, Elisabeth Mocaër, M. Maus, Y. Torrens, Sophie Reibel and Philippe Marin and has published in prestigious journals such as PLoS ONE, The Journal of Comparative Neurology and Journal of Neurochemistry.

In The Last Decade

Sylvie Bretin

17 papers receiving 354 citations

Peers

Sylvie Bretin
Mari Sild Canada
Sylvie Bretin
Citations per year, relative to Sylvie Bretin Sylvie Bretin (= 1×) peers Mari Sild

Countries citing papers authored by Sylvie Bretin

Since Specialization
Citations

This map shows the geographic impact of Sylvie Bretin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Bretin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Bretin more than expected).

Fields of papers citing papers by Sylvie Bretin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Bretin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Bretin. The network helps show where Sylvie Bretin may publish in the future.

Co-authorship network of co-authors of Sylvie Bretin

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Bretin. A scholar is included among the top collaborators of Sylvie Bretin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Bretin. Sylvie Bretin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hémon, Patrice, Christelle Le Dantec, Loukas Chatzis, et al.. (2023). High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome. Journal of Autoimmunity. 149. 103147–103147. 2 indexed citations
2.
Silva, Joana, Carina Soares‐Cunha, Christina Dalla, et al.. (2020). Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology. Molecular Psychiatry. 26(10). 5899–5911. 10 indexed citations
3.
Pilar-Cuéllar, Fuencisla, Elena Castro, Sylvie Bretin, et al.. (2019). S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 93. 205–213. 10 indexed citations
4.
Bretin, Sylvie, et al.. (2019). A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 231–240. 21 indexed citations
5.
Morley‐Fletcher, Sara, Anna Rita Zuena, Jérôme Mairesse, et al.. (2018). The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats. Neuropharmacology. 135. 284–296. 21 indexed citations
6.
Silva, Joana, et al.. (2018). A novel modulator of AMPA receptors against Alzheimer's Disease pathology: the first in vivo evidence. European Neuropsychopharmacology. 28. S54–S55. 2 indexed citations
7.
Mendez‐David, Indira, Jean‐Philippe Guilloux, Mariusz Papp, et al.. (2017). S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. Frontiers in Pharmacology. 8. 462–462. 40 indexed citations
8.
Bretin, Sylvie, Caroline Louis, Laure Seguin, et al.. (2017). Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors. PLoS ONE. 12(9). e0184429–e0184429. 22 indexed citations
9.
Bretin, Sylvie, et al.. (2017). Synergistic enhancing-memory effect of donepezil and S 47445, an AMPA positive allosteric modulator, in middle-aged and aged mice. Psychopharmacology. 235(3). 771–787. 6 indexed citations
10.
Giralt, Albert, María Ángeles Gómez‐Climent, Sylvie Bretin, et al.. (2017). The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice. Neuropharmacology. 123. 395–409. 21 indexed citations
11.
Calabrese, Francesca, et al.. (2017). Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats. Pharmacological Research. 121. 59–69. 20 indexed citations
13.
Bretin, Sylvie, Stefania Maccari, Sara Morley‐Fletcher, et al.. (2016). The positive modulator of AMPA receptors, S 47445, improved behavior, cognitive, neurochemical and synaptic proteins modifications induced by prenatal restraint stress. European Neuropsychopharmacology. 26. S447–S447. 2 indexed citations
14.
Bretin, Sylvie, Denis J. David, Alain M. Gardier, et al.. (2015). P.1.g.019 Antidepressant- and anxiolytic-like properties of S 47445, a novel positive allosteric modulator of AMPA type glutamate receptors. European Neuropsychopharmacology. 25. S248–S249. 2 indexed citations
15.
Bretin, Sylvie, Véronique Rogemond, Philippe Marin, et al.. (2006). Calpain product of WT‐CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. Journal of Neurochemistry. 98(4). 1252–1265. 72 indexed citations
16.
Maus, M., Y. Torrens, C. Gauchy, et al.. (2006). 2‐Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor‐2 by distinct mechanisms. Journal of Neurochemistry. 96(3). 815–824. 11 indexed citations
17.
Bretin, Sylvie, Sophie Reibel, Jacques Glowinski, et al.. (2005). Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. The Journal of Comparative Neurology. 486(1). 1–17. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026